Rett syndrome: Pathogenicity and regulation of MECP2 (human) and Mecp2 (mouse) genes and their protein products...

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Rett syndrome is a rare neurodevelopmental disorder primarily caused by mutations in the X-linked methyl CpG-binding protein 2 (MECP2) gene.
• The MECP2 protein's unstructured nature and diverse conformations present challenges in understanding its pathogenic mechanisms.
• Previous research has implicated various cellular processes in Rett syndrome, but a comprehensive review is lacking.

Purpose of the Study:

• To provide a detailed review of the cellular pathways involved in the pathogenicity and regulation of MECP2 in Rett syndrome.
• To consolidate information on mechanisms including apoptosis, mitophagy, and key signaling cascades.
• To facilitate further research by offering a comprehensive summary of these complex pathways.

Main Methods:

• Literature review and synthesis of existing research on Rett syndrome and MECP2.
• Detailed examination of molecular mechanisms such as apoptosis, mitophagy, and signaling pathways.
• Categorization and summarization of findings related to PI3K/AKT/mTOR, BMP signaling, NF-kB, STAT3, and Wnt/β-catenin pathways.

Main Results:

• Mutations in MECP2 disrupt normal cellular functions, leading to Rett syndrome.
• Key pathways investigated include programmed cell death (apoptosis), self-degradation of mitochondria (mitophagy), and crucial signaling cascades.
• The PI3K/AKT/mTOR, BMP signaling, NF-kB, STAT3, and Wnt/β-catenin pathways are significantly implicated in MECP2 regulation and pathogenicity.

Conclusions:

• Understanding the intricate interplay of these pathways is vital for elucidating Rett syndrome pathogenesis.
• This comprehensive review serves as a foundational resource for researchers investigating therapeutic strategies.
• Further exploration of these molecular mechanisms holds promise for developing targeted treatments for Rett syndrome.